Letter to the editors of the Journal of Cancer Research and Clinical Oncology.

Matthes, H; Hofheinz, R-D; Bar-Sela, G; Galun, D; Martin, D; Huber, R; Langhorts, J; Matthiessen, P F; Schad, F

Matthes, H; Hofheinz, R-D; Bar-Sela, G; Galun, D; Martin, D; Huber, R; Langhorts, J; Matthiessen, P F; Schad, F.

Afiliação

Matthes H; Institute for Social Medicine, Epidemiology and Health Economics and Department of Gastroenterology, Infectiology and Rheumatology, Charité Universitätsmedizin Berlin, Charité CCM and CBF, Berlin, Germany. hmatthes@havelhoehe.de.
Hofheinz RD; Interdisciplinary Tumour Centre Mannheim, University Medicine of Mannheim, Mannheim, Germany.
Bar-Sela G; Emek Medical Center, Afula, Israel.
Galun D; Clinical Center of Serbia, Belgrade and Medical School, University of Belgrade, Belgrade, Serbia.
Martin D; Gerhard Kienle Chair for Medical Theory, Integrative and Anthroposophical Medicine, Department of Human Medicine, Faculty of Health, University of Witten/Herdecke, Witten/Herdecke, Germany.
Huber R; Center for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, University of Freiburg, Freiburg, Germany.
Langhorts J; Clinic for Integrative Medicine and Naturopathy, Social Foundation Bamberg, Klinikum am Bruderwald, Bamberg, Germany.
Matthiessen PF; Institute for Integrative Medicine at the University of Witten/Herdecke, Witten/Herdecke, Germany.
Schad F; Department of Oncology, Hospital Havelhöhe, Berlin, Germany.

J Cancer Res Clin Oncol ; 145(9): 2405-2407, 2019 09.

Article em En | MEDLINE | ID: mdl-31115671

Assuntos

Erva-de-Passarinho; Oncologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Erva-de-Passarinho Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google